Brain Chemistry of Infants with HIV Exposure

Brain Chemistry of Infants with HIV Exposure

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description
Most of the infants born to HIV-positive mothers are HIV-exposed but uninfected. HIV exposure in infants may cause brain developmental delays. This study will look for changes in the brain that might have occurred due to HIV exposure in infants. These measurements can lead to novel insights regarding the impact of HIV exposure in infants' brain and potentially guide the development of new therapies to mitigate abnormal brain development.

Eligibility and criteria
IRB Number:
24-022219
Clinical trial phase:
N/A
Official title:
Brain Chemistry of Infants with HIV Exposure

What to expect
For this research to be successful, we need to work with children and parents (preferably mothers). The visit will include: 
  • Developmental assessment and questionnaires
  • MRI Scan

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.